Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6...
Published: May 2022 - Pages: 127
Cells Expressing T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4-Leu 3 or CD4) Drugs in Development by Therap...
Published: May 2022 - Pages: 35
Inactive Tyrosine Protein Kinase Transmembrane Receptor ROR1 (Neurotrophic Tyrosine Kinase Receptor Related 1 or ROR1 or...
Published: May 2022 - Pages: 36
Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN) Drugs in Development by Therapy Areas and Indications, Stages, M...
Published: May 2022 - Pages: 35
Cells Expressing Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) Drugs in Development by Thera...
Published: May 2022 - Pages: 37
Interleukin 1 Receptor Like 2 (IL 36 Receptor or Interleukin 1 Receptor Related Protein 2 or IL1RL2) Drugs in Developmen...
Published: May 2022 - Pages: 38
Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) Drugs in Development by Therapy...
Published: Apr 2022 - Pages: 71
Cell Division Protein FtsZ (ftsz) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...
Published: Apr 2022 - Pages: 36
Dystrophin (DMD) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players,...
Published: Apr 2022 - Pages: 133
Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) Drugs in Development by Therapy Areas and Indicatio...
Published: Apr 2022 - Pages: 119
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, ...
Published: Apr 2022 - Pages: 152
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) Drugs in Deve...
Published: Apr 2022 - Pages: 138
Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) Drugs in De...
Published: Apr 2022 - Pages: 100
Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) Development by Therapy Areas and Indicatio...
Published: Mar 2022 - Pages: 46
Protein Kinase C Theta Type (nPKC Theta or PRKCQ or EC 2.7.11.13) Development by Therapy Areas and Indications, Stages, ...
Published: Mar 2022 - Pages: 31
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stage...
Published: Mar 2022 - Pages: 283
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stage...
Published: Mar 2022 - Pages: 216
Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) Development by Therapy Ar...
Published: Mar 2022 - Pages: 134
Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) Development by Therapy Areas and I...
Published: Mar 2022 - Pages: 122
Toll Like Receptor 3 (CD283 or TLR3) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and K...
Published: Mar 2022 - Pages: 73
